Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ASHOK M PATEL

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1124091798
CMS profile
1163983
Location
LARGO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$1,038.62

49 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,038.62 49

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ASHOK M PATEL

NPI 1124091798 · CMS profile ID 1163983

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

LARGO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1124091798?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ASHOK M PATEL, NPI 1124091798, CMS profile ID 1163983. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1124091798?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ASHOK M PATEL, NPI 1124091798, CMS profile ID 1163983. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1124091798?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ASHOK M PATEL, NPI 1124091798, CMS profile ID 1163983, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1124091798?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

49 matching records · $1,038.62 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 49 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–49 of 49.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ITI, Inc. $21.8512/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040651463 CMS
Corium, LLC $17.0712/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978634027 CMS
Otsuka America Pharmaceutical, Inc. $27.6512/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014673365 CMS
ABBVIE INC. $20.4412/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083443 CMS
Supernus Pharmaceuticals, Inc. $15.7812/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053294081 CMS
ABBVIE INC. $28.4111/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083441 CMS
ABBVIE INC. $20.9511/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083439 CMS
ITI, Inc. $18.8610/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040651457 CMS
Neurocrine Biosciences, Inc. $27.2210/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052123549 CMS
Neurocrine Biosciences, Inc. $17.2410/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052123555 CMS
IDORSIA PHARMACEUTICALS US INC $19.4110/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034250287 CMS
Otsuka America Pharmaceutical, Inc. $22.0110/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014673353 CMS
Otsuka America Pharmaceutical, Inc. $24.6309/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014673343 CMS
Neurocrine Biosciences, Inc. $24.4909/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052123489 CMS
ITI, Inc. $25.0909/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040651449 CMS
ABBVIE INC. $27.5908/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083437 CMS
ITI, Inc. $15.2208/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040651441 CMS
Otsuka America Pharmaceutical, Inc. $18.3008/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014673331 CMS
Otsuka America Pharmaceutical, Inc. $23.4307/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014673319 CMS
ABBVIE INC. $13.6007/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083435 CMS
Teva Pharmaceuticals USA, Inc. $31.3007/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056780433 CMS
Lundbeck LLC $16.1306/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032311271 CMS
IDORSIA PHARMACEUTICALS US INC $17.6006/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034250279 CMS
Janssen Pharmaceuticals, Inc $33.9106/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987770233 CMS
ABBVIE INC. $27.7505/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083433 CMS
Teva Pharmaceuticals USA, Inc. $20.4305/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056780337 CMS
Almatica Pharma LLC $25.7505/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993451235 CMS
ITI, Inc. $12.8405/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040651433 CMS
ABBVIE INC. $21.1005/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083431 CMS
Tris Pharma Inc $18.3504/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059350851 CMS
IDORSIA PHARMACEUTICALS US INC $22.1304/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034250271 CMS
ITI, Inc. $19.6504/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040651425 CMS
IDORSIA PHARMACEUTICALS US INC $13.9604/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034250263 CMS
Ironshore Pharmaceuticals Inc. $16.4904/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060464847 CMS
ABBVIE INC. $25.3304/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083427 CMS
ABBVIE INC. $12.7704/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083429 CMS
Tris Pharma Inc $16.4703/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059350809 CMS
ITI, Inc. $22.8803/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040651417 CMS
ABBVIE INC. $29.9203/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083425 CMS
Tris Pharma Inc $21.2703/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059350773 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.9603/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055530723 CMS
ABBVIE INC. $14.0702/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083423 CMS
IDORSIA PHARMACEUTICALS US INC $19.8602/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034250255 CMS
Ironshore Pharmaceuticals Inc. $21.3802/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060465175 CMS
ABBVIE INC. $29.3202/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998083421 CMS
IDORSIA PHARMACEUTICALS US INC $18.5401/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034250247 CMS
Supernus Pharmaceuticals, Inc. $15.7801/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053294077 CMS
Ironshore Pharmaceuticals Inc. $16.3301/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060465237 CMS
Otsuka America Pharmaceutical, Inc. $17.1101/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014673307 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $61.64 3
PY2020 $159.87 9
PY2021 $1,289.36 36
PY2022 $875.20 43
PY2023 $1,038.62 49
PY2024 $1,610.25 80
PY2025 $1,981.39 118

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,435.00 2
PY2024 Principal investigator $7,512.26 11
PY2023 Principal investigator $28,504.20 11
PY2022 Principal investigator $41,769.98 4
PY2021 Principal investigator $27,285.85 9
PY2020 Principal investigator $25,874.85 3
PY2019 Principal investigator $161,728.29 8

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $5,000.00 12/09/2023 Non-covered Recipient Entity
VANTAGE CLINICAL TRIALS LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-ARM STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF AVP-786 (DEUDEXTROMETHORPHAN HYDROBROMIDE [D6-DM]/QUINIDINE SULFATE [Q]) FOR THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA No dispute reported 06/30/2026 1014046457
Principal investigator 1 LivaNova USA, Inc. $792.00 09/06/2023 Non-covered Recipient Entity
VANTAGE CLINICAL TRIALS LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043035095
Principal investigator 1 LivaNova USA, Inc. $1,668.00 08/10/2023 Non-covered Recipient Entity
VANTAGE CLINICAL TRIALS LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043035073
Principal investigator 1 LivaNova USA, Inc. $525.00 08/08/2023 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1043069419
Principal investigator 1 LivaNova USA, Inc. $295.00 08/08/2023 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1043069617
Principal investigator 1 LivaNova USA, Inc. $792.00 07/18/2023 Non-covered Recipient Entity
VANTAGE CLINICAL TRIALS LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043035057
Principal investigator 1 LivaNova USA, Inc. $1,155.00 07/05/2023 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1043069007
Principal investigator 1 LivaNova USA, Inc. $876.00 06/01/2023 Non-covered Recipient Entity
VANTAGE CLINICAL TRIALS LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043035041
Principal investigator 1 LivaNova USA, Inc. $5,000.00 04/26/2023 Non-covered Recipient Entity
VANTAGE CLINICAL TRIALS LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043035007
Principal investigator 1 LivaNova USA, Inc. $7,716.00 04/26/2023 Non-covered Recipient Entity
VANTAGE CLINICAL TRIALS LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043035023
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $4,685.20 03/23/2023 Non-covered Recipient Entity
VANTAGE CLINICAL TRIALS LLC
A MULTI-CENTER, RANDOMIZED, CONTROLLED TRIAL TO EVALUATE THE EFFECTIVENESS OF A DIGITAL THERAPEUTIC (CT-152) AS ADJUNCTIVE THERAPY IN ADULT SUBJECTS DIAGNOSED WITH MAJOR DEPRESSIVE DISORDER No dispute reported 06/30/2026 1014042283